PaxMedica,'s market value is the price at which a share of PaxMedica, trades on a public exchange. It measures the collective expectations of PaxMedica Common Stock investors about its performance. PaxMedica, is trading at 1.0E-4 as of the 8th of January 2026, a No Change since the beginning of the trading day. The stock's lowest day price was 1.0E-4. With this module, you can estimate the performance of a buy and hold strategy of PaxMedica Common Stock and determine expected loss or profit from investing in PaxMedica, over a given investment horizon. Check out PaxMedica, Correlation, PaxMedica, Volatility and PaxMedica, Alpha and Beta module to complement your research on PaxMedica,.
Please note, there is a significant difference between PaxMedica,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if PaxMedica, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PaxMedica,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
PaxMedica, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to PaxMedica,'s pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of PaxMedica,.
0.00
11/09/2025
No Change 0.00
0.0
In 2 months and 2 days
01/08/2026
0.00
If you would invest 0.00 in PaxMedica, on November 9, 2025 and sell it all today you would earn a total of 0.00 from holding PaxMedica Common Stock or generate 0.0% return on investment in PaxMedica, over 60 days. PaxMedica, is related to or competes with Orphazyme A/S. PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapie... More
PaxMedica, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure PaxMedica,'s pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess PaxMedica Common Stock upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for PaxMedica,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as PaxMedica,'s standard deviation. In reality, there are many statistical measures that can use PaxMedica, historical prices to predict the future PaxMedica,'s volatility.
PaxMedica, is out of control given 3 months investment horizon. PaxMedica Common Stock maintains Sharpe Ratio (i.e., Efficiency) of 0.19, which implies the firm had a 0.19 % return per unit of risk over the last 3 months. We have collected data for sixteen different technical indicators, which can help you to evaluate if expected returns of 42.74% are justified by taking the suggested risk. Use PaxMedica, Coefficient Of Variation of 846.55, risk adjusted performance of 0.0975, and Variance of 364506.68 to evaluate company specific risk that cannot be diversified away. PaxMedica, holds a performance score of 15 on a scale of zero to a hundred. The company holds a Beta of 1.19, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, PaxMedica, will likely underperform. Use PaxMedica, standard deviation, as well as the relationship between the maximum drawdown and day median price , to analyze future returns on PaxMedica,.
Auto-correlation
0.07
Virtually no predictability
PaxMedica Common Stock has virtually no predictability. Overlapping area represents the amount of predictability between PaxMedica, time series from 9th of November 2025 to 9th of December 2025 and 9th of December 2025 to 8th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of PaxMedica Common Stock price movement. The serial correlation of 0.07 indicates that barely 7.0% of current PaxMedica, price fluctuation can be explain by its past prices.
Correlation Coefficient
0.07
Spearman Rank Test
0.29
Residual Average
0.0
Price Variance
0.0
PaxMedica Common Stock lagged returns against current returns
Autocorrelation, which is PaxMedica, pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting PaxMedica,'s pink sheet expected returns. We can calculate the autocorrelation of PaxMedica, returns to help us make a trade decision. For example, suppose you find that PaxMedica, has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
PaxMedica, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If PaxMedica, pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if PaxMedica, pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in PaxMedica, pink sheet over time.
Current vs Lagged Prices
Timeline
PaxMedica, Lagged Returns
When evaluating PaxMedica,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of PaxMedica, pink sheet have on its future price. PaxMedica, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, PaxMedica, autocorrelation shows the relationship between PaxMedica, pink sheet current value and its past values and can show if there is a momentum factor associated with investing in PaxMedica Common Stock.
Regressed Prices
Timeline
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Other Information on Investing in PaxMedica, Pink Sheet
PaxMedica, financial ratios help investors to determine whether PaxMedica, Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PaxMedica, with respect to the benefits of owning PaxMedica, security.